Physician profile
Donald K Eckhardt
NPI 1154417442
$2,381.85
in general payments reported to CMS, 2019-2025
33 companies · $543 in 2025
The $543 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $334 · 2020: $213 · 2021: $155 · 2022: $330 · 2023: $314 · 2024: $492 · 2025: $543.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,349.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $342.36 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $280.03 | 2020-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $229.28 | 2022-2025 | |
| Abbvie INC. | $210.97 | 2019-2023 | Lo Loestrin Fe |
| Avanos Medical | $147.71 | 2019-2024 | On-Q* Pump and Accessories |
| Merck Sharp & Dohme LLC | $136.25 | 2019-2022 | |
| Hologic Sales and Service, LLC | $111.58 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Bayer Healthcare Pharmaceuticals INC. | $87.38 | 2019-2022 | |
| Smith+Nephew, INC. | $78.79 | 2019-2025 | Pico 7 |
| Myovant Sciences INC. | $73.71 | 2021-2022 | |
| Daiichi Sankyo INC. | $60.69 | 2021-2023 | Injectafer |
| Innovation Technologies INC | $58.38 | 2024-2025 | Irrisept |
| Evofem Biosciences, INC. | $56.36 | 2021-2022 | |
| Millicent US INC | $47.64 | 2020-2025 | Femlyv |
| Roche Diagnostics Corporation | $47.42 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $43.85 | 2020-2024 | Ova1 |
| Shield Therapeutics INC | $43.35 | 2023 | Accrufer |
| Pfizer INC. | $38.99 | 2024 | |
| Organon LLC | $36.98 | 2022-2025 | Jada System |
| Exact Sciences Corporation | $35.34 | 2023-2025 | Cologuard Collection Kit |
| Avion Pharmaceuticals | $32.33 | 2023 | Balcoltra |
| Ethicon US, LLC | $19.45 | 2025 | Stratafix, Dermabond Prineo, Vistaseal |
| Pacira Pharmaceuticals Incorporated | $19.42 | 2021 | |
| Abbott Laboratories | $18.17 | 2022 | |
| Radius Health, INC. | $16.42 | 2023 | Tymlos |
| Coopersurgical, INC. | $15.73 | 2019 | |
| Mission Pharmacal Company | $14.98 | 2021 | |
| Exeltis, USA INC. | $14.55 | 2022 | |
| Ferring Pharmaceuticals INC. | $13.97 | 2019 | |
| Sumitomo Pharma America, INC. | $13.90 | 2024 | Gemtesa |
| Amag Pharmaceuticals, INC. | $12.54 | 2020 | |
| Allergan, INC. | $12.07 | 2020 | |
| Renovia INC | $11.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Eckhardt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.